Trial intelligence / Profile preview

Subcutaneous versus intravenous insulin therapy for ICU hyperglycemia after oral intake initiation

2007-002773-30Phase 4Completed

Sponsor
Herz-, Thorax- und Gefäßchirurgische Anästhesie und Intensivmedizin
Start
Aug 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of insulin aspart and insulin detemir in Stress Hyperglycemia (SH) and hyperglycemia (2 arms), sponsored by Herz-, Thorax- und Gefäßchirurgische Anästhesie und Intensivmedizin. Primary endpoints: Glycemic control outside target range and Hypoglycemia occurrence. Started Aug 2007; status: completed.

02

Drugs

insulin aspartinsulin detemir
03

Conditions

Stress Hyperglycemia (SH)hyperglycemia

Beyond the preview

Go deeper on 2007-002773-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002773-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call